Z-2209-2023 Class II Ongoing
FDA device recall Z-2209-2023 was initiated by Cytocell Ltd. on May 24, 2023 and is designated Class II. Reason for recall: DNAs used during the manufacture of two affected models were accidentally inverted during manufacturing. The recall status is ongoing. Affected quantity: 60 units.
Recall details
- Product Type
- Devices
- Report Date
- Jul 26, 2023
- Initiation Date
- May 24, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 60 units
Product description
RET Proximal Probe. Used in Fluorescence in situ hybridization (FISH), a laboratory technique for detecting and locating a specific DNA sequence on a chromosome.
Reason for recall
DNAs used during the manufacture of two affected models were accidentally inverted during manufacturing.
Distribution pattern
US Nationwide distribution in the states of CA, FL, OH, & SC.
Code information
Catalog No. LPS508-A; UDI-DI: 05055844900509; Lot No. 076763, 077253, 080125, 080763, 082128, 083041, 083246, 083555.
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2209-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026